Stephen S. Grubbs

1.2k total citations
30 papers, 538 citations indexed

About

Stephen S. Grubbs is a scholar working on Oncology, Economics and Econometrics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Stephen S. Grubbs has authored 30 papers receiving a total of 538 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 12 papers in Economics and Econometrics and 10 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Stephen S. Grubbs's work include Economic and Financial Impacts of Cancer (10 papers), Ethics in Clinical Research (7 papers) and Health Systems, Economic Evaluations, Quality of Life (6 papers). Stephen S. Grubbs is often cited by papers focused on Economic and Financial Impacts of Cancer (10 papers), Ethics in Clinical Research (7 papers) and Health Systems, Economic Evaluations, Quality of Life (6 papers). Stephen S. Grubbs collaborates with scholars based in United States, Malaysia and Canada. Stephen S. Grubbs's co-authors include Andrew L. Himelstein, Charles L. Shapiro, Paul J. Novotny, Jared C. Foster, Ronald S. Go, James Khatcheressian, Charles L. Loprinzi, Rui Qin, Drew K. Seisler and John D. Roberts and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Stephen S. Grubbs

30 papers receiving 519 citations

Peers

Countries citing papers authored by Stephen S. Grubbs

Since Specialization

Citations

This map shows the geographic impact of Stephen S. Grubbs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen S. Grubbs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen S. Grubbs more than expected).

Fields of papers citing papers by Stephen S. Grubbs

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen S. Grubbs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen S. Grubbs. The network helps show where Stephen S. Grubbs may publish in the future.

Co-authorship network of co-authors of Stephen S. Grubbs

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen S. Grubbs. A scholar is included among the top collaborators of Stephen S. Grubbs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen S. Grubbs. Stephen S. Grubbs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	ASCO Patient-Centered Cancer Care Certification (APC4) pilot: Assessing and improving care delivery gaps. 2023 ·JCO Oncology Practice ·John V. Cox, (unknown), Eric Martin, (unknown), (unknown), (unknown), (unknown), Stephen S. Grubbs, Blasé N. Polite	1
2	The impact of geography on receipt of cancer treatment in Montana. 2022 ·Journal of Clinical Oncology ·Jack O. Hensold, (unknown), Janette K. Merrill, (unknown), Diane Ng, Stephen S. Grubbs	1
3	Can measuring quality lead to improvement? Evidence from international participants of ASCO’s quality oncology practice initiative (QOPI®) during 2015-2017 2018 ·Annals of Oncology ·Mohammad Jahanzeb, Terry Gilmore, (unknown), Stephen S. Grubbs, Douglas W. Blayney, John Hamm, Arif H. Kamal, Ronan J. Kelly, Éric Martin, (unknown), Robert D. Siegel, (unknown), (unknown), Carolyn B. Hendricks	1
4	The Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) Made Simple for Medical and Radiation Oncologists 2018 ·JAMA Oncology ·Ryan Jones, (unknown), (unknown), Stephen S. Grubbs, Hak Choy, (unknown)	10
5	Cost-Effectiveness Analysis of Monthly Zoledronic Acid, Zoledronic Acid Every 3 Months, and Monthly Denosumab in Women With Breast Cancer and Skeletal Metastases: CALGB 70604 (Alliance) 2017 ·Journal of Clinical Oncology ·Charles L. Shapiro, James P. Moriarty, Stacie B. Dusetzina, Andrew L. Himelstein, Jared C. Foster, Stephen S. Grubbs, Paul J. Novotny, Bijan J. Borah	49
6	ReCAP: Clinical Trial Assessment of Infrastructure Matrix Tool to Improve the Quality of Research Conduct in the Community 2016 ·Journal of Oncology Practice ·Eileen Dimond, Robin Zoň, Bryan J. Weiner, Diane St. Germain, Andrea Denicoff, (unknown), (unknown), Randall Teal, Marjorie J. Good, Worta McCaskill‐Stevens, Stephen S. Grubbs, (unknown), (unknown)	9
7	Glucocorticoids Suppress Renal Cell Carcinoma Progression by Enhancing Na,K-ATPase Beta-1 Subunit Expression 2015 ·PLoS ONE ·(unknown), Sonali P. Barwe, Seung Joon Lee, (unknown), Omar E. Franco, Simon W. Hayward, Robert Damoiseaux, Stephen S. Grubbs, Nicholas J. Petrelli, Ayyappan K. Rajasekaran	15
8	CALGB 70604 (Alliance): A randomized phase III study of standard dosing vs. longer interval dosing of zoledronic acid in metastatic cancer. 2015 ·Journal of Clinical Oncology ·Andrew L. Himelstein, Rui Qin, Paul J. Novotny, Drew K. Seisler, James Khatcheressian, John D. Roberts, Stephen S. Grubbs, Tracey L. O’Connor, Douglas Weckstein, Charles L. Loprinzi, Charles L. Shapiro	14
9	Managing Cumulative Expectations in Oncology: Challenges and Potential Solutions 2014 ·American Society of Clinical Oncology Educational Book ·Amy P. Abernethy, Stephen S. Grubbs	6
10	Eliminating racial disparities in colorectal cancer in the real world: it took a village. 2014 ·PubMed ·Stephen S. Grubbs, Blasé N. Polite, (unknown), (unknown), (unknown), Nora Katurakes, (unknown), Electra D. Paskett	2
11	Refining the clinical trials assessment of infrastructure matrix tool. 2014 ·Journal of Clinical Oncology ·Bryan J. Weiner, Randall Teal, Eileen Dimond, Marjorie J. Good, (unknown), Diane St. Germain, Andrea Denicoff, Worta J. McCaskill-Stevens, (unknown), Robin Zoň, Stephen S. Grubbs	1
12	Use of the National Cancer Institute Community Cancer Centers Program Screening and Accrual Log to Address Cancer Clinical Trial Accrual 2014 ·Journal of Oncology Practice ·Diane St. Germain, Andrea Denicoff, Eileen Dimond, (unknown), Rebecca A. Enos, Maria Magdalena González, Kathy Wilkinson, Michelle A. Mathiason, (unknown), (unknown), Worta McCaskill‐Stevens, Donna Bryant, Michael A. Thompson, Stephen S. Grubbs, Ronald S. Go	37
13	Quality of life (QOL) and toxicity among patients in CALGB 80405. 2013 ·Journal of Clinical Oncology ·Michelle J. Naughton, Deborah Schrag, Alan P. Venook, Donna Niedzwiecki, Roger T. Anderson, Heinz‐Josef Lenz, Stephen S. Grubbs	8
14	The New National Cancer Institute National Clinical Trials Network 2012 ·American Society of Clinical Oncology Educational Book ·Stephen S. Grubbs	1
15	Tracking clinical trial accrual strategies and barriers via a Web-based screening tool 2009 ·Journal of Clinical Oncology ·Stephen S. Grubbs, Maria Gonzalez, Mark J. Krasna, Robert D. Siegel, Donna Bryant, Loren K. Tschetter, (unknown), (unknown), (unknown), Andrea Denicoff	2
16	Applying a conceptual model for examining health‐related quality of life in long‐term breast cancer survivors: CALGB study 79804 2008 ·Psycho-Oncology ·Electra D. Paskett, James E. Herndon, Jeannette M. Day, Nancy Stark, Eric P. Winer, Stephen S. Grubbs, (unknown), Charles L. Shapiro, Marcy A. List, Martee L. Hensley, Michelle Naughton, Alice B. Kornblith, Karleen Habin, Gini F. Fleming, Marisa A. Bittoni	30
17	Barriers exist to patient participation in clinical trials 2005 ·Journal of Clinical Oncology ·Michael J. Guarino, Gregory A. Masters, (unknown), David D. Biggs, Stephen S. Grubbs, Andrew L. Himelstein, Scott E. Martin, (unknown), Anthony J. Guarino, (unknown)	6
18	A Dose-Escalation Study of Weekly Topotecan, Cisplatin, and Gemcitabine Front-Line Therapy in Patients with Inoperable Non-Small Cell Lung Cancer 2002 ·The Oncologist ·Michael J. Guarino, Charles Schneider, Stephen S. Grubbs, David D. Biggs, Andrew L. Himelstein, (unknown), (unknown)	9
19	Phase II study of recombinant alpha-2 interferon in resistant multiple myeloma. 1985 ·Journal of Clinical Oncology ·J J Costanzi, M. Robert Cooper, J.H. Scarffe, Howard Ozer, Stephen S. Grubbs, R. W. Ferraresi, Richard B. Pollard, Robert J. Spiegel	77
20	The thoracic windows for electrical ventricular defibrillation current 1977 ·American Heart Journal ·L. A. Geddes, Stephen S. Grubbs, Pearce Wilcox, Willis A. Tacker	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact